Posts by author
Knarik Arakelyan
Immunotherapy’s Hidden Burden: Rethinking Toxicity in the Era of Breakthroughs
Immunotherapy has redefined cancer care—offering survival where little once existed, and in some cases, the possibility of long-term remission. But as its use expands across tumor types and earlier lines of treatment, a more complex reality is coming into focus:…
From Silence to Presence: Dr Christian Ntizimira on Reimagining End-of-Life Care
Dr Christian Ntizimira, MD, MMsGHE, Founder and Executive Director of the African Center for Research on End-of-Life Care (ACREOL), and author of “The Safari Concept: An African Framework on End-of-Life Care,” speaks about dignity, suffering, and reimagining care at the…
Rewriting the Surgical Narrative: Dr Lazaros Papadopoulos On Breast Cancer Care, Mentorship, and the Meaning of Small Changes
“Life is often a sequence of chance events, and many times we are called to rewrite our own narrative.” For Dr Lazaros Papadopoulos, that idea is not abstract. It is the thread that connects a childhood shaped by admiration for…
CancerWorld #115 (May 2026)
In oncology, progress is measured in survival rates, response curves, and treatment gains. But those numbers rest on a quieter assumption: that health systems can deliver what science makes possible. When they cannot, progress becomes uneven—not in discovery, but in…
CancerWorld | The Max Foundation – Special Issue 2026
25 Years of TKIs in CML: A Revolution and a Responsibility Twenty-five years ago, the arrival of imatinib changed the course of a disease and the lives of countless people diagnosed with it. Chronic myeloid leukemia (CML), once defined by…
“Medicine is Deeply Relational: The Human Heart of Oncology in the Age of AI”
From genetics to palliative care, clinician-scientist Rita Canário reflects on building a career in Oncology that bridges research, patient care, and the human side of medicine and why this integration is essential for the future of oncology. “I was never…
CancerWorld #114 (April 2026)
In oncology, we are trained to deliver hope alongside difficult truths. We speak about survival rates, probabilities, and outcomes. In conflict settings, those terms lose stability. What does survival mean when hospitals are destroyed, treatments cannot reach patients, and people…
Translating Global Excellence into Local Impact: Dr Fatjona Kraja and the Challenge of Transforming Radiation Oncology in Albania
Radiation oncology is one of the most technologically sophisticated and intellectually demanding disciplines in modern medicine. Yet, for Dr Fatjona Kraja, newly appointed Faculty member of the European School of Oncology (ESO) College, the field is defined not only by…
Leading with Listening: Why Isabel Rubio Believes Europe’s Cancer Future Depends on Trust, Equity, and Political Courage
Leadership in oncology is often measured in breakthroughs, budgets, and policy frameworks. But for Dr. Isabel Rubio, President of the European Cancer Organisation (ECO), leadership begins somewhere far more intimate: in listening. “Progress happens only when expertise is matched by…
CancerWorld #113 (March 2026)
Scientific discovery drives oncology forward, but progress only truly begins when knowledge is turned into action. Every issue of CancerWorld explores the people, ideas, and systems shaping the future of oncology. Scientific breakthroughs remain essential, but their true value emerges…